FYN overexpression partially protected Fgf18-CKO mice from hypertrophy (Fig. 7b), as well as cardiac function (Fig. 7c, Supplementary Table 9), myocardial fibrosis (Fig. 7d), and hydroxyproline content (Fig. 7e). Here, FYN is linked to Myocardial fibrosis.